Regenicin Inc (RGIN)

[lamlam]

Here is a response I recieved from Chris Hadsall. It's positive info for the future!


Thank you for contacting us, essentially there is not a lot I can say because of FDA and SEC regulations but we hopefully will submit the IND in the near future and start the clinical trials before the end of the year. The orphan status gives you some tax incentives, extra protection and an advocate inside the FDA, which will be helpful moving forward. It's still an extremely risky situation so I'm cautiously optimistic.



Regards,



Chris Hadsall